Dr Sam Hare has authored numerous peer-reviewed publications, some of which are listed below:
COVID-19 Imaging Pathways in the UK
Managing high clinical suspicion COVID-19 inpatients with negative RT-PCR: a pragmatic and limited role for thoracic CT
Ambulatory percutaneous lung biopsy with early discharge and Heimlich valve management of iatrogenic pneumothorax: more for less
Exogenous lipoid pneumonia mimicking multifocal bronchogenic carcinoma
Systemic arterial air embolism after percutaneous lung biopsy
Primary adenocarcinoma of the lung: A pictorial review of recent updates
The radiological spectrum of pulmonary lymphoproliferative disease
Dr Sam Hare: A chest radiologist’s take on COVID-19
A device that drains air from the chest is being used to treat thousands of patients who have suffered a collapsed lung - while they relax at home.
Patients in London are receiving earlier lung cancer diagnosis and treatment thanks to a innovative way of performing lung biopsies at Barnet Hospital, Royal Free London NHS Foundation Trust.
Fast and cheap test raises hope against lung cancer.The method allows patients to spend only an hour in an outpatient clinic, rather than a day in a hospital bed. Even if their lung collapsed — a complication of lung biopsies — patients could still be sent home.
A pioneering two-in-one lung cancer treatment is being used to both diagnose and destroy hard-to-reach tumours in just half an hour – allowing thousands of NHS patients to avoid the need for invasive, life-changing surgery.
Congratulations to Dr Sam Hare, Consultant Thoracic Radiologist (pictured holding trophy) and colleagues from Barnet Hospital, Royal Free London NHS Foundation Trust for winning the first ever NHS Innovation Challenge Prize for Cancer.
8. NHS England
The NHS Innovation Challenge Prizes exist to encourage, recognise and reward these frontline ideas, and support innovators in getting them embedded across the NHS. Dr Sam Hare, said: “It is a huge privilege to be honoured with this NHS Innovation award. This is an exciting opportunity to help shape a new and brighter landscape for lung cancer patients."